BACTERIAL SECONDARY METABOLITES DISTINGUISH COMMENSAL AND PATHOGENIC E COLI
BACTERIAL SECONDARY METABOLITES DISTINGUISH COMMENSAL AND PATHOGENIC E COLI
批准号:
7721554
负责人:
SCOTT J. HULTGREN
金额:
$0.27万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-02-01 至 2009-01-31
关键词:
Biological AssayClinicalClinical MicrobiologyCollaborationsComputer Retrieval of Information on Scientific Projects DatabaseDataDetectionDiagnosticEnterobactinEscherichia coliFundingGenesGenomicsGrantInstitutionIronIron Chelating AgentsPathogenesisPatientsPilot ProjectsProductionResearchResearch PersonnelResourcesRoleSiderophoresSourceStable Isotope LabelingUnited States National Institutes of HealthUniversitiesUrinary tractUrinary tract infectionUrineVirulenceVirulentWashingtonbasefollow-upin vivoinstrumentationpathogenuptakeurinary
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Project Summary: Genomic and transcriptional data suggest a prominent role for bacterial iron acquisition during urinary tract infection (UTI) pathogenesis. One means by which Escherichia coli, the major cause of UTI, obtain iron from their surrounding is secretion of small iron-chelating molecules called siderophores. While all E. coli are capable of secreting an ancestral siderophore called enterobactin, many clinical strains have acquired genes for secretion and uptake of chemically distinct siderophores, which may have a special role in pathogenesis. We have used the LCQ-DECA to develop an LC-MS/MS (MRM) assay for qualitative and quantitative studies of siderophore production between E. coli strains. This assay uses stable isotope labeling to compare gut and urinary tract isolates of E. coli obtained through a collaboration with clinical researchers at the University of Washington's Urinary Tract Infection Research Center. From this study, we have obtained evidence suggesting that urinary pathogens are often selected from available gut strains based on their ability to produce the highest levels of two specific siderophores. This assay will be used to identify particularly virulent E. coli strains in initial clinical microbiology studies. With more sensitive instrumentation, we will follow up on preliminary in vivo data to adapt this assay to perform in vivo diagnostics through detection of virulence-associated siderophores directly from patient urine. We intend to use the mass spectrometric approaches developed here to begin pilot studies on in vivo microbiologic diagnostics for clinical use.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10162824
-
项目类别:
-
资助金额:$4.72万
-
财政年份:2021
-
负责人:SCOTT J. HULTGREN
-
依托单位:
Innovative Strategies to Combat Antibiotic-resistant Infections
-
批准号:10162823
-
项目类别:
-
资助金额:$215.68万
-
财政年份:2021
-
负责人:SCOTT J. HULTGREN
-
依托单位:
Innovative Strategies to Combat Antibiotic-resistant Infections
-
批准号:10352464
-
项目类别:
-
资助金额:$216.51万
-
财政年份:2021
-
负责人:SCOTT J. HULTGREN
-
依托单位:
Innovative Strategies to Combat Antibiotic-resistant Infections
-
批准号:10577797
-
项目类别:
-
资助金额:$229.03万
-
财政年份:2021
-
负责人:SCOTT J. HULTGREN
-
依托单位:
Administrative Core
-
批准号:10577798
-
项目类别:
-
资助金额:$6.27万
-
财政年份:2021
-
负责人:SCOTT J. HULTGREN
-
依托单位:
Development of anti-adhesin mAbs and high-affinity ligand mimetics to treat and prevent UTIs
-
批准号:10162827
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2021
-
负责人:SCOTT J. HULTGREN
-
依托单位:
Administrative Core
-
批准号:10352465
-
项目类别:
-
资助金额:$36.09万
-
财政年份:2021
-
负责人:SCOTT J. HULTGREN
-
依托单位:
Development of anti-adhesin mAbs and high-affinity ligand mimetics to treat and prevent UTIs
-
批准号:10577806
-
项目类别:
-
资助金额:$37.79万
-
财政年份:2021
-
负责人:SCOTT J. HULTGREN
-
依托单位:
Development of anti-adhesin mAbs and high-affinity ligand mimetics to treat and prevent UTIs
-
批准号:10352469
-
项目类别:
-
资助金额:$36.09万
-
财政年份:2021
-
负责人:SCOTT J. HULTGREN
-
依托单位:
SMALL MOLECULE BACTERIAL LECTIN ANTAGONISTS FOR UTI TREATMENT AND PREVENTION
-
批准号:9234333
-
项目类别:
-
资助金额:$48.57万
-
财政年份:2017
-
负责人:SCOTT J. HULTGREN
-
依托单位:
ORALLY ACTIVE MANNOSIDES SUBVERT ANTIBIOTIC RESISTANCE IF E COLI IN BLADDER
-
批准号:8361464
-
项目类别:
-
资助金额:$1.24万
-
财政年份:2011
-
负责人:SCOTT J. HULTGREN
-
依托单位:
RATIONAL DESIGN OF MANNOSIDES FOR INHIBITION OF FIMH AND TREATMENT OF UTI
-
批准号:7938679
-
项目类别:
-
资助金额:$43.05万
-
财政年份:2009
-
负责人:SCOTT J. HULTGREN
-
依托单位:
MOLECULAR BASIS OF E. COLI ADHESINS IN BLADDER DISORDERS
-
批准号:7994021
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2009
-
负责人:SCOTT J. HULTGREN
-
依托单位:
RATIONAL DESIGN OF MANNOSIDES FOR INHIBITION OF FIMH AND TREATMENT OF UTI
-
批准号:7815787
-
项目类别:
-
资助金额:$47.43万
-
财政年份:2009
-
负责人:SCOTT J. HULTGREN
-
依托单位:
EFFECT OF CRANBERRY CONSTITUENTS ON UTI PATHOGENESIS
-
批准号:7000294
-
项目类别:
-
资助金额:$35.36万
-
财政年份:2004
-
负责人:SCOTT J. HULTGREN
-
依托单位:
EFFECT OF CRANBERRY CONSTITUENTS ON UTI PATHOGENESIS
-
批准号:6836034
-
项目类别:
-
资助金额:$35.79万
-
财政年份:2004
-
负责人:SCOTT J. HULTGREN
-
依托单位:
EFFECT OF CRANBERRY CONSTITUENTS ON UTI PATHOGENESIS
-
批准号:7163793
-
项目类别:
-
资助金额:$36.12万
-
财政年份:2004
-
负责人:SCOTT J. HULTGREN
-
依托单位:
EFFECT OF CRANBERRY CONSTITUENTS ON UTI PATHOGENESIS
-
批准号:6751354
-
项目类别:
-
资助金额:$35.26万
-
财政年份:2004
-
负责人:SCOTT J. HULTGREN
-
依托单位:
Molecular and Epidemiologic Basis of UTI in Women
-
批准号:9128767
-
项目类别:
-
资助金额:$105.66万
-
财政年份:2002
-
负责人:SCOTT J. HULTGREN
-
依托单位:
ORWH: SCOR--Sex /Gender Factors Affecting Women's Health
-
批准号:7026829
-
项目类别:
-
资助金额:$3.52万
-
财政年份:2002
-
负责人:SCOTT J. HULTGREN
-
依托单位:
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
-
批准号:31070748
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:Christine Nardini
-
依托单位: